Cancer Studies
Jujube and Cancer
I have grown jujube fruits, dried them and given them as gifts for years. Little did I know about their powerful anticancer potential until running across a recent study. Jujube has powerful anti-cancer effects against cervical and breast cancers. Researchers noted, "These results indicated that Jujube may be a natural potential and promising agent to prevent or treat human cancers." There are apparently at least three compounds in this fruit with anti-cancer potential. In the study noted a water soluble extract was used. Anti-cancer effects were time and dose dependent.
Abedini MR, Erfanian N, Nazem H, Jamali S, Hoshyar R. Anti-proliferative and apoptotic effects of
Ziziphus Jujube on cervical and breast cancer cells. Avicenna Journal of Phytomedicine
. 2016;6(2):142-148.
Vitamin C and Cancer
Most studies which purport to be high dose vitamin C are pretty modest. It is always interesting to see the results when dosages are increased to levels of intake comparable to what animals that synthesize their own vitamin C produce within their bodies. For example, a goat can produce 10-20 grams of vitamin C a day. A factor which contributes to a good deal of human suffering and misery is the loss of the ability to synthesize vitamin C. Humans share this unique biochemistry with guinea pigs, primates, and a species of fruit eating bat.
In a Korean study, terminally ill cancer patients were given 10 grams of vitamin C by injection every third day and 4 grams of vitamin C orally on a daily basis. Korean researchers noted, "In symptom scale, the patients reported significantly lower scores for fatigue, nausea/vomiting, pain, and appetite loss after administration of vitamin C (p<0.005).
" It is unfortunate that the work of Klenner, Stone, and Levy on the power of high dose and consistent intake of vitamin C is ignored by modern medicine.
Yeom CH, Jung GC, Song KJ.
Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration. J Korean Med Sci. 2007 Feb;22(1):7-11.
No comments:
Post a Comment